Linaliglip Dapamet 1000 Mg Tablet

LINALIGLIP DAPAMET 1000 mg Tablet is a fixed-dose combination antidiabetic medication that contains:

• Dapagliflozin 10 mg – an SGLT2 inhibitor

• Linagliptin 5 mg – a DPP-4 inhibitor

• Metformin 1000 mg – a biguanide

This combination works through complementary mechanisms to effectively control blood glucose levels in adults with type 2 diabetes mellitus (T2DM). It is used when monotherapy or dual therapy does not provide adequate glycemic control.

USES

• Treatment of Type 2 Diabetes Mellitus (T2DM) in adults

• To improve glycemic control when diet, exercise, and either dual therapy or monotherapy are inadequate

• May provide cardiovascular and renal benefits (due to dapagliflozin component)

• Can be part of combination therapy with other antidiabetic agents as prescribed by a physician

BENEFITS

• Triple mechanism of action for effective and sustained blood glucose control:

  • Dapagliflozin: Promotes glucose excretion via the kidneys

  • Linagliptin: Enhances incretin levels, stimulating insulin secretion

  • Metformin: Reduces hepatic glucose production and improves insulin sensitivity

• Weight reduction or weight neutrality (mostly from dapagliflozin)

• Low risk of hypoglycemia when used alone

• Cardiovascular and renal protection (associated with dapagliflozin)

• Improves patient compliance with once-daily oral dosing

SIDE EFFECTS

Common Side Effects:

• Genital infections (fungal)

• Urinary tract infections

• Increased urination

• Diarrhea, nausea, or stomach discomfort (mainly due to Metformin)

• Headache

• Nasopharyngitis (cold-like symptoms)

Less Common / Serious Side Effects:

• Hypoglycemia (especially when combined with insulin or sulfonylureas)

• Dehydration or low blood pressure

• Lactic acidosis (a rare but serious risk with Metformin; more likely in patients with kidney impairment)

• Pancreatitis (rare, but possible with DPP-4 inhibitors like Linagliptin)

• Diabetic ketoacidosis (rare, but a known risk with SGLT2 inhibitors)

• Allergic skin reactions (rash, itching)